These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hyperkalemias]. Radó J, Haris A. Orv Hetil; 1999 Nov 21; 140(47):2611-8. PubMed ID: 10613044 [Abstract] [Full Text] [Related]
3. Drug-induced hyperkalemia. Ben Salem C, Badreddine A, Fathallah N, Slim R, Hmouda H. Drug Saf; 2014 Sep 21; 37(9):677-92. PubMed ID: 25047526 [Abstract] [Full Text] [Related]
6. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients. Indermitte J, Burkolter S, Drewe J, Krähenbühl S, Hersberger KE. Drug Saf; 2007 Sep 21; 30(1):71-80. PubMed ID: 17194172 [Abstract] [Full Text] [Related]
7. Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia. Kuijvenhoven MA, Haak EA, Gombert-Handoko KB, Crul M. Int J Clin Pharm; 2013 Dec 21; 35(6):1099-104. PubMed ID: 23974985 [Abstract] [Full Text] [Related]
8. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? Ahmed A. J Am Geriatr Soc; 2002 Jul 21; 50(7):1297-300. PubMed ID: 12133029 [Abstract] [Full Text] [Related]